limitations of genome sequencing in cancer treatment
Published 4 years ago • 436 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:32
genomic sequencing as a driver of advancements in pediatric hematology
-
1:04
overcoming the limits to widespread ngs implementation
-
1:02
the impact of sequencing in aml
-
1:07
single-cell whole genome measurement of genomic heterogeneity and clonal evolution in myeloma
-
1:54
genome sequencing and transcription analysis: improving mm understanding
-
0:58
the role of whole exome sequencing in aml and the importance of molecular genetics
-
3:48
trials of interest in newly diagnosed myeloma presented at ims 2024
-
0:52
genomic profiling at diagnosis of myeloid neoplasms
-
1:01
next-generation sequencing: a breakthrough in sequencing technology
-
1:42
applying next-generation sequencing in the diagnosis of rare inherited anemias
-
2:25
how next-generation sequencing will change clinical practice
-
0:53
the future of next-generation sequencing assays in myeloma treatment
-
2:39
shallow wgs vs conventional cytogenetic analysis for diagnosing and stratifying mds
-
1:38
the genomic definition of high-risk myeloma
-
1:46
ctc whole-genome sequencing vs fish to monitor the emergence of multiple myeloma high-risk subclones
-
1:41
whole genome sequencing in cll
-
3:33
the value of wgs and whole transcriptome sequencing in the diagnosis of hematological malignancies
-
1:00
proof of principle to progress treatments